Regulator’s experience of clinical trials during the Covid-19 pandemic (Part 2) – what we have learned
Posted by:
Gail Francis, Martin O'Kane, Kirsty Wydenbach and Lisa Campbell, Posted on:
-
Categories:
Good clinical practice, Inside the Inspectorate
...COVID-19 assessors developed new ways of working and through prioritisation activities and close engagement with researchers, assessed and approved trials in shortened time frames whilst maintaining high levels of scientific...
